GLP-1s are not currently approved for binge-eating, though there are some clinical trials in progress
Individuals who have a genetic and family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Semaglutide Market Key Players: Novo Nordisk A/S Eli Lilly and Company Pfizer Inc
As the dose rises, people may start to notice less intense cravings, a smaller appetite, smaller portions, less hunger between meals or more ease stopping when full
Ozempic can sometimes exacerbate certain conditions, so its crucial your prescriber has the full picture
First, fiber will slow down digestion, keeping you fuller for a more extended period